EquitiesMedium impact
Insulet Stock: A High-Quality Growth Story At A Reasonable PEG (NASDAQ:PODD)
seekingalpha.com·3 hours ago·Global·1 min read
Source: seekingalpha.com
Insulet (PODD) Buy thesis: Omnipod automation drives recurring revenue, low pump penetration fuels growth; valuation suggests 60% upside.
See more.
Insulet ( PODD ) has pulled back 44% in the last year despite continuing to show some of the strongest growth metrics in the medtech industry.
While the market...
Related news
Equities
Markets open higher; IT stocks lead gains as crude falls, semiconductor rout weighs on sentiment
thehindubusinessline.com
Equities
Non-AI Nifty suddenly beating Nasdaq, South Korea & Taiwan bourses: Is the global tech trade finally reversing?
economictimes.indiatimes.com
Equities
Kuaishou shares fall after Tencent joins $2.8 billion raise for Kling AI subsidiary
cnbc.com
Equities
Why Bank of Baroda paid ₹5,700 crore to settle NMC Health dispute in Abu Dhabi: Explained
thehindu.com
Equities
Keurig Dr Pepper Disappointed Me (Rating Downgrade) (NASDAQ:KDP)
seekingalpha.com
Equities
ON Semiconductor: Mispriced 800V-1200V AI Power And Physical AI Shift (NASDAQ:ON)
seekingalpha.com